These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


294 related items for PubMed ID: 23117173

  • 1. Microwave assisted synthesis and anti-influenza virus activity of 1-adamantyl substituted N-(1-thia-4-azaspiro[4.5]decan-4-yl)carboxamide derivatives.
    Göktaş F, Vanderlinden E, Naesens L, Cesur N, Cesur Z.
    Bioorg Med Chem; 2012 Dec 15; 20(24):7155-9. PubMed ID: 23117173
    [Abstract] [Full Text] [Related]

  • 2. Novel N-(1-thia-4-azaspiro[4.5]decan-4-yl)carboxamide derivatives as potent and selective influenza virus fusion inhibitors.
    Göktaş F, Özbil M, Cesur N, Vanderlinden E, Naesens L, Cesur Z.
    Arch Pharm (Weinheim); 2019 Nov 15; 352(11):e1900028. PubMed ID: 31531897
    [Abstract] [Full Text] [Related]

  • 3. Synthesis and anti-coronavirus activity of a series of 1-thia-4-azaspiro[4.5]decan-3-one derivatives.
    Apaydın ÇB, Cesur N, Stevaert A, Naesens L, Cesur Z.
    Arch Pharm (Weinheim); 2019 Jun 15; 352(6):e1800330. PubMed ID: 31073993
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Arylazolyl(azinyl)thioacetanilide. Part 9: Synthesis and biological investigation of thiazolylthioacetamides derivatives as a novel class of potential antiviral agents.
    Zhan P, Wang L, Liu H, Chen X, Li X, Jiang X, Zhang Q, Liu X, Pannecouque C, Naesens L, De Clercq E, Liu A, Du G.
    Arch Pharm Res; 2012 Jun 15; 35(6):975-86. PubMed ID: 22870806
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Synthesis and antiviral activity of substituted bisaryl amide compounds as novel influenza virus inhibitors.
    Hao LH, Li YP, He WY, Wang HQ, Shan GZ, Jiang JD, Li YH, Li ZR.
    Eur J Med Chem; 2012 Sep 15; 55():117-24. PubMed ID: 22824205
    [Abstract] [Full Text] [Related]

  • 11. Design and synthesis of 1,2-annulated adamantane piperidines with anti-influenza virus activity.
    Zoidis G, Kolocouris N, Naesens L, De Clercq E.
    Bioorg Med Chem; 2009 Feb 15; 17(4):1534-41. PubMed ID: 19195900
    [Abstract] [Full Text] [Related]

  • 12. Influence of an additional amino group on the potency of aminoadamantanes against influenza virus A. II - Synthesis of spiropiperazines and in vitro activity against influenza A H3N2 virus.
    Fytas C, Kolocouris A, Fytas G, Zoidis G, Valmas C, Basler CF.
    Bioorg Chem; 2010 Dec 15; 38(6):247-51. PubMed ID: 20926112
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Anti-influenza virus activity of Myrica rubra leaf ethanol extract evaluated using Madino-Darby canine kidney (MDCK) cells.
    Mochida K.
    Biosci Biotechnol Biochem; 2008 Nov 15; 72(11):3018-20. PubMed ID: 18997411
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Synthesis and anti-viral activity of azolo-adamantanes against influenza A virus.
    Zarubaev VV, Golod EL, Anfimov PM, Shtro AA, Saraev VV, Gavrilov AS, Logvinov AV, Kiselev OI.
    Bioorg Med Chem; 2010 Jan 15; 18(2):839-48. PubMed ID: 20006516
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Biological evaluation of anti-influenza viral activity of semi-synthetic catechin derivatives.
    Song JM, Park KD, Lee KH, Byun YH, Park JH, Kim SH, Kim JH, Seong BL.
    Antiviral Res; 2007 Nov 15; 76(2):178-85. PubMed ID: 17709148
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 15.